|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
5.40/9.99
|
企业价值
299.41B
|
资产负债 |
每股账面净值
17.19
|
现金流量 |
现金流量率
0.06
|
损益表 |
收益
47.99B
|
每股收益
23.40
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/10/31 23:26 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States. |